Early research (Phase 1)Study completedNCT03663998What this trial is testingOptimising DNA Vaccinations in Healthy VolunteersWho this might be right forHIV-1-infection Imperial College London 36
Testing effectiveness (Phase 2)Study completedNCT03208231What this trial is testingEvaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral TherapyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 61
Large-scale testing (Phase 3)Study completedNCT02157311What this trial is testing4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV PatientsWho this might be right forHIV-1 Infection ANRS, Emerging Infectious Diseases 100
Not applicableStudy completedNCT01048671What this trial is testingManagement of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)Who this might be right forHIV Infections Merck Sharp & Dohme LLC 482
Post-approval studies (Phase 4)Ended earlyNCT01245101What this trial is testingAddition of Raltegravir to Established Antiretroviral Suppressive TherapyWho this might be right forHIV University of Miami 15
Large-scale testing (Phase 3)Study completedNCT01968551What this trial is testingPhase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive AdultsWho this might be right forHIV-1HIV InfectionsAcquired Immunodeficiency Syndrome Gilead Sciences 158
Early research (Phase 1)Study completedNCT00002353What this trial is testingA Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human SubjectsWho this might be right forHIV Infections United Biomedical
Early research (Phase 1)Study completedNCT05585307What this trial is testingStudy of Novel Antiretrovirals in Participants With HIV-1Who this might be right forHIV-1-infection Gilead Sciences 49
Large-scale testing (Phase 3)Study completedNCT00711009What this trial is testingStudy Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)Who this might be right forHuman Immunodeficiency Virus Infection Abbott 206
Post-approval studies (Phase 4)WithdrawnNCT00782301What this trial is testingMaraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsWho this might be right forHepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic ViiV Healthcare
Post-approval studies (Phase 4)UnknownNCT01201239What this trial is testingEfficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese PatientsWho this might be right forHIV Shanghai Public Health Clinical Center 50
Not applicableStudy completedNCT00000900What this trial is testingThe Effects of Illnesses on HIV Levels in the BodyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 26
Large-scale testing (Phase 3)Study completedNCT02605954What this trial is testingSafety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected AdultsWho this might be right forHIV-1 Infection Gilead Sciences 275
Not applicableStudy completedNCT05634265What this trial is testingSocial Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART StudyWho this might be right forHIV-1-infectionAdherence, MedicationDepression University of Washington 55
Post-approval studies (Phase 4)UnknownNCT02337322What this trial is testingImmune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted DarunavirWho this might be right forAcquired Immune Deficiency Syndrome Virus Juan A. Arnaiz 104
Early research (Phase 1)Study completedNCT03552536What this trial is testingMK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002)Who this might be right forHIV-1 Infection Merck Sharp & Dohme LLC 5
Early research (Phase 1)Study completedNCT04771754What this trial is testingThe Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy VolunteersWho this might be right forHIV-1-infection on Healthy Volunteers Chelsea and Westminster NHS Foundation Trust 16
Not applicableStudy completedNCT00014937What this trial is testingSimplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination RegimenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 240
Testing effectiveness (Phase 2)Study completedNCT01903031What this trial is testingEvaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ARTWho this might be right forHIV-1 Infection Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84
Testing effectiveness (Phase 2)Study completedNCT00848211What this trial is testingClinical Study of TUTI-16 in Asymptomatic HIV-1 Infected SubjectsWho this might be right forHIV Infections Thymon, LLC 24